79127685 - BOEHRINGER INGELHEIM BIOXCELLENCE

Information

• Trademark
• 79127685

• Source

• Serial Number

  79127685

• Registration Number

  4634652

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 16 - Paper, cardboard and goods made from these materials, not included in other classes
  • 35 - Advertising
  • 38 - Telecommunications
  • 40 - Treatment of materials
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  September 14, 2012
  12 years ago

• Registration Date

  November 11, 2014
  10 years ago

• Transaction Date

  November 05, 2024
  4 months ago

• Status Date

  September 29, 2023
  a year ago

• Published for Opposition Date

  August 26, 2014
  10 years ago

• Location Date

  September 29, 2023
  a year ago

• Status Code

  707

• Employee Name

  DALIER, JOHN

• Attorney Docket Number

  TE/3975-188

  Attorney Name

  Max Moskowitz

  Law Office Assigned Location Code

  L60

• Owners

  • Boehringer Ingelheim Pharma GmbH & Co. KG

Case File Statements

• GS0401: Custom manufacture of pharmaceuticals, pharmaceutical ingredients, chemical products and chemical intermediates as well as of biological and biochemical products for third parties; treatment of biological materials, namely, batch treatment services with respect to microorganisms and proteins
• GS0381: Transmitting medical and scientific information by means of a database
• GS0051: pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; and pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders; preparations for destroying vermin; fungicides, herbicides; bacteriological cultures for medical and veterinary purposes as well as culture media for bacteriological cultures; bacteriological preparations for medical and veterinary use for the treatment of diseases and disorders of the alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system and for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders; biological preparations for medical and for veterinary purposes for the treatment of diseases and disorders of the alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system and for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders; biochemical preparations for medical and veterinary purposes for the treatment of diseases and disorders of the alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system and for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders; chemical preparations for pharmaceutical or medical purposes, namely, for diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; and pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders; ferments for pharmaceutical purposes; vaccines; culture media for microorganisms; plasters and dressings for medical purposes
• GS0161: Printed matter, namely, newspapers, photographs, magazines, books, printed periodicals, newsletters, and brochures all in the field of pharmaceutical preparations; paper; cardboard; goods made from paper and cardboard, namely, boxes of paper and cardboard boxes; cardboard packaging, namely, pharmaceutical packaging; patient record cards and prescription pads; in the field of in the fields of medicine and pharmaceuticals; printed teaching and instructional materials, namely, pharmaceutical information leaflets;books in the fields of medicine and pharmaceuticals; printed publications, namely, magazines, newsletters,pamphlets, reports, instructional and information leaflets, and posters in the fields of medicine and pharmaceuticals; paper packaging, namely, packaging containers of paper; stationery; printed instructional and teaching materials relating to the pharmaceutical, health care and medical fields, in the field of research, medicine, veterinary and laboratory techniques
• PM0001: BOEHRINGER INGELHEIM BIO XCELLENCE; BOEHRINGER INGELHEIM BIO EXCELLENCE
• TF0000: as to "INGELHEIM"
• CC0000: Color is not claimed as a feature of the mark.
• GS0351: Compilation of data in computer databases, in particular in the field of biotechnology and biopharmaceutics; management in connection with the commercialization of technical or scientific results; management relating to the organisation of research; creation, namely, writing and compiling of manufacturing and registration dossiers for pharmaceutical products for third parties; office work, namely, operation of registration proceedings for pharmaceutical products
• GS0011: Chemical, biochemical and biological products, substances and preparations for industrial and scientific purposes as well as for research purposes
• GS0441: Medical and veterinary consulting; providing medical and veterinary information via the Internet; all the aforementioned consultations and services also provided through a database; providing medical information via the Internet
• GS0421: Scientific and technological services, namely, scientific research, analysis and testing of active substances, medicine and treatment in the field of biotechnology; research and development of new products for other sand scientific laboratory services in the field of biotechnology; performance of chemical, biochemical and biological analysis; development of biological, biotechnological and pharmaceutical analysis and their application for others; technical and scientific consultancy, particularly in the field of biotechnology; scientific research; conducting clinical trials for others of pharmaceutical products; providing scientific information via the Internet in the field of pharmaceutical, health care and medical fields; scientific research consulting in the field of pharmaceutical, health care and medical fields

Case File Event Statements

• 4/11/2013 - 11 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 4/15/2013 - 11 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 4/15/2013 - 11 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 4/19/2013 - 11 years ago

  4 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 4/19/2013 - 11 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 4/20/2013 - 11 years ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 4/22/2013 - 11 years ago

  7 - NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW Type: RFWR

• 4/25/2013 - 11 years ago

  8 - NON-FINAL ACTION WRITTEN Type: CNRT

• 4/26/2013 - 11 years ago

  9 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 4/26/2013 - 11 years ago

  10 - REFUSAL PROCESSED BY MPU Type: RFRR

• 4/26/2013 - 11 years ago

  11 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 5/19/2013 - 11 years ago

  12 - REFUSAL PROCESSED BY IB Type: RFNT

• 10/25/2013 - 11 years ago

  13 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 10/31/2013 - 11 years ago

  14 - PAPER RECEIVED Type: MAIL

• 11/1/2013 - 11 years ago

  15 - ASSIGNED TO LIE Type: ALIE

• 11/12/2013 - 11 years ago

  16 - ASSIGNED TO LIE Type: ALIE

• 11/20/2013 - 11 years ago

  17 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 11/20/2013 - 11 years ago

  18 - AMENDMENT FROM APPLICANT ENTERED Type: ACEC

• 12/5/2013 - 11 years ago

  19 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 12/6/2013 - 11 years ago

  20 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 1/7/2014 - 11 years ago

  24 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 12/21/2013 - 11 years ago

  21 - WITHDRAWN FROM PUB - OG REVIEW QUERY Type: PBCR

• 1/6/2014 - 11 years ago

  22 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX

• 1/7/2014 - 11 years ago

  23 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 1/7/2014 - 11 years ago

  25 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 1/7/2014 - 11 years ago

  26 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 1/7/2014 - 11 years ago

  27 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 1/7/2014 - 11 years ago

  28 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 1/20/2014 - 11 years ago

  29 - WITHDRAWN FROM PUB - OG REVIEW QUERY Type: PBCR

• 1/21/2014 - 11 years ago

  30 - PREVIOUS ALLOWANCE WITHDRAWN-TIMELY AAU Type: ZZAX

• 1/23/2014 - 11 years ago

  31 - PRIORITY ACTION WRITTEN Type: CPRA

• 1/23/2014 - 11 years ago

  32 - PRIORITY ACTION E-MAILED Type: GPRA

• 1/23/2014 - 11 years ago

  33 - NOTIFICATION OF PRIORITY ACTION E-MAILED Type: GPRN

• 7/22/2014 - 10 years ago

  34 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 7/22/2014 - 10 years ago

  35 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 7/22/2014 - 10 years ago

  36 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 7/23/2014 - 10 years ago

  37 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 7/23/2014 - 10 years ago

  38 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 8/6/2014 - 10 years ago

  39 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 8/6/2014 - 10 years ago

  40 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 8/6/2014 - 10 years ago

  41 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 8/22/2014 - 10 years ago

  42 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 8/26/2014 - 10 years ago

  43 - PUBLISHED FOR OPPOSITION Type: PUBO

• 8/26/2014 - 10 years ago

  44 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 9/17/2014 - 10 years ago

  45 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR

• 9/17/2014 - 10 years ago

  46 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 10/2/2014 - 10 years ago

  47 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX

• 11/11/2014 - 10 years ago

  48 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 2/11/2015 - 10 years ago

  49 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 4/3/2015 - 9 years ago

  50 - FINAL DISPOSITION PROCESSED Type: FIMP

• 4/3/2015 - 9 years ago

  51 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 4/24/2015 - 9 years ago

  52 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 11/11/2019 - 5 years ago

  53 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3

• 11/12/2020 - 4 years ago

  54 - TEAS SECTION 71 RECEIVED Type: ES71

• 1/21/2021 - 4 years ago

  55 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE

• 5/18/2022 - 2 years ago

  56 - POST REGISTRATION ACTION MAILED - SEC.71 Type: PR71

• 9/29/2022 - 2 years ago

  57 - INTERNATIONAL REGISTRATION RENEWED Type: RNWL

• 11/17/2022 - 2 years ago

  58 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 11/17/2022 - 2 years ago

  59 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 11/17/2022 - 2 years ago

  60 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Type: EWAF

• 11/17/2022 - 2 years ago

  61 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR

• 11/17/2022 - 2 years ago

  62 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 11/18/2022 - 2 years ago

  63 - TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED Type: EROP

• 11/26/2022 - 2 years ago

  64 - POST REGISTRATION ACTION MAILED - SEC.71 Type: PR71

• 5/18/2023 - a year ago

  65 - TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED Type: EROP

• 9/29/2023 - a year ago

  66 - REGISTERED - PARTIAL SEC 71 ACCEPTED Type: 71.P

• 9/29/2023 - a year ago

  67 - NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED Type: NA71

• 11/11/2023 - a year ago

  68 - COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED Type: REM4

• 6/14/2024 - 9 months ago

  69 - PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INPR

• 7/16/2024 - 8 months ago

  70 - GENERIC MADRID TRANSACTION CREATED Type: XXCR

• 11/5/2024 - 4 months ago

  73 - TEAS SECTION 71 & 15 RECEIVED Type: ES75

• 10/7/2024 - 5 months ago

  72 - PARTIAL INVALIDATION PROCESSED BY THE IB Type: INNP

• 7/16/2024 - 8 months ago

  71 - GENERIC MADRID TRANSACTION SENT TO IB Type: XXSS